SlideShare a Scribd company logo
TORCH Infections
AHMED BAMAGA
MBBS
KAUH
TORCH Infections
• T=toxoplasmosis
• O=other (syphilis)
• R=rubella
• C=cytomegalovirus (CMV)
• H=herpes simplex (HSV)
• You are taking care of a term newborn
male with birth weight/length <10th %ile.
Physical exam is normal except for a
slightly enlarged liver span. A CBC is
significant for low platelets.
• What, if anything, do you worry about?
• How do you proceed with a work-up?
Index of Suspicion
• When do you think of TORCH
infections?
• IUGR infants
• HSM
• Thrombocytopenia
• Unusual rash
• Concerning maternal history
• “Classic” findings of any specific infection
Diagnosing TORCH Infection
!!!!!!DO NOT USE TORCH TITERS!!!!!!
Diagnosing TORCH Infection
• Good maternal/prenatal history
• Remember most infections of concern are
mild illnesses often unrecognized
• Thorough exam of infant
• Directed labs/studies based on most
likely diagnosis…
• Again, DO NOT USE TORCH TITERS!
Screening TORCH Infections
• Retrospective study of 75/182 infants with IUGR who
were screened for TORCH infections
• 1/75 with clinical findings, 11/75 with abnl lab findings
• All patients screened:
• TORCH titers, urine CMV culture, head US
• Only 3 diagnosed with infection
• NONE by TORCH titer!!
• Overall cost of all tests = $51,715
• “Shotgun” screening approach NOT cost effective nor
particularly useful
• Diagnostic work-up should be logical and directed by
history/exam findings
Khan, NA, Kazzi, SN. Yield and costs of screening growth-retarded infants for torch
Toxoplasmosis
• Caused by protozoan – Toxoplasma gondii
• Domestic cat is the definitive host with
infections via:
• Ingestion of cysts (meats, garden products)
• Contact with oocysts in feces
• Much higher prevalence of infection in
European countries (ie France, Greece)
• Acute infection usually asymptomatic
• 1/3 risk of fetal infection with primary maternal
infection in pregnancy
• Infection rate higher with infxn in 3rd trimester
• Fetal death higher with infxn in 1st trimester
Clinical Manifestations
• Most (70-90%) are asymptomatic at birth
• Classic triad of symptoms:
• Chorioretinitis
• Hydrocephalus
• Intracranial calcifications
• Other symptoms include fever, rash, HSM,
microcephaly, seizures, jaundice,
thrombocytopenia, lymphadenopathy
• Initially asymptomatic infants are still at high risk
of developing abnormalities, especially
chorioretinitis
Chorioretinitis of congenital toxo
Diagnosis
• Maternal IgG testing indicates past
infection (but when…?)
• Can be isolated in culture from
placenta, umbilical cord, infant serum
• PCR testing on WBC, CSF, placenta
• Not standardized
• Newborn serologies with IgM/IgA
Toxo Screening
• Prenatal testing with varied sensitivity
not useful for screening
• Neonatal screening with IgM testing
implemented in some areas
• Identifies infected asymptomatic infants
who may benefit from therapy
Prevention and Treatment
• Treatment for pregnant mothers diagnosed with acute toxo
• Spiramycin daily
• Macrolide antibiotic
• Small studies have shown this reduces likelihood of congenital
transmission (up to 50%)
• If infant diagnosed prenatally, treat mom
• Spiramycin, pyrimethamine (anti-malarial, dihydrofolate reductase
inhib), and sulfadiazine (sulfa antibiotic)
• Leucovorin rescue with pyrimethamine
• Symptomatic infants
• Pyrimethamine (with leucovorin rescue) and sulfadiazine
• Treatment for 12 months total
• Asymptomatic infants
• Course of same medications
• Improved neurologic and developmental outcomes demonstrated
(compared to untreated pts or those treated for only one month)
Syphilis
• Treponema pallidum (spirochete)
• Transmitted via sexual contact
• Placental transmission as early as 6wks
gestation
• Typically occurs during second half
• Mom with primary or secondary syphilis more
likely to transmit than latent disease
• Large decrease in congenital syphilis since
late 1990s
• In 2002, only 11.2 cases/100,000 live births
reported
From MMWR –
Aug 2004
From MMWR –
Aug 2004
Congenital Syphilis
• 2/3 of affected live-born infants are
asymptomatic at birth
• Clinical symptoms split into early or late
(2 years is cutoff)
• 3 major classifications:
• Fetal effects
• Early effects
• Late effects
Clinical Manifestations
• Fetal:
• Stillbirth
• Neonatal death
• Hydrops fetalis
• Intrauterine death in 25%
• Perinatal mortality in 25-30% if
untreated
Clinical Manifestations
• Early congenital (typically 1st 5 weeks):
• Cutaneous lesions (palms/soles)
• HSM
• Jaundice
• Anemia
• Snuffles
• Periostitis and metaphysial dystrophy
• Funisitis (umbilical cord vasculitis)
Periostitis of long bones seen
in neonatal syphilis
Clinical Manifestations
• Late congenital:
• Frontal bossing
• Short maxilla
• High palatal arch
• Hutchinson teeth
• 8th nerve deafness
• Saddle nose
• Perioral fissures
• Can be prevented with appropriate treatment
Hutchinson teeth – late result of
congenital syphilis
Diagnosing Syphilis
(Not in Newborns)
• Available serologic testing
• RPR/VDRL: nontreponemal test
• Sensitive but NOT specific
• Quantitative, so can follow to determine disease activity
and treatment response
• MHA-TP/FTA-ABS: specific treponemal test
• Used for confirmatory testing
• Qualitative, once positive always positive
• RPR/VDRL screen in ALL pregnant women
early in pregnancy and at time of birth
• This is easily treated!!
CDC Definition of Congenital
Syphilis
• Confirmed if T. pallidum identified in skin
lesions, placenta, umbilical cord, or at
autopsy
• Presumptive diagnosis if any of:
• Physical exam findings
• CSF findings (positive VDRL)
• Osteitis on long bone x-rays
• Funisitis (“barber shop pole” umbilical cord)
• RPR/VDRL >4 times maternal test
• Positive IgM antibody
Diagnosing Congenital Syphilis
• IgG can represent maternal antibody,
not infant infection
• This is VERY intricate and often
confusing
• Consult your RedBook (or peds ID folks)
when faced with this situation
Treatment
• Penicillin G is THE drug of choice for ALL
syphilis infections
• Maternal treatment during pregnancy very
effective (overall 98% success)
• Treat newborn if:
• They meet CDC diagnostic criteria
• Mom was treated <4wks before delivery
• Mom treated with non-PCN med
• Maternal titers do not show adequate response
(less than 4-fold decline)
Rubella
• Single-stranded RNA virus
• Vaccine-preventable disease
• No longer considered endemic in the U.S.
• Mild, self-limiting illness
• Infection earlier in pregnancy has a
higher probability of affected infant
Copyright ©2006 American Academy of Pediatrics
Meissner, H. C. et al. Pediatrics 2006;117:933-935
Reported rubella and CRS: United States, 1966-2004
Clinical Manifestations
• Sensorineural hearing loss (50-75%)
• Cataracts and glaucoma (20-50%)
• Cardiac malformations (20-50%)
• Neurologic (10-20%)
• Others to include growth retardation,
bone disease, HSM, thrombocytopenia,
“blueberry muffin” lesions
“Blueberry muffin” spots representing
extramedullary hematopoesis
Diagnosis
• Maternal IgG may represent immunization or
past infection - Useless!
• Can isolate virus from nasal secretions
• Less frequently from throat, blood, urine, CSF
• Serologic testing
• IgM = recent postnatal or congenital infection
• Rising monthly IgG titers suggest congenital
infection
• Diagnosis after 1 year of age difficult to
establish
Treatment
• Prevention…immunize, immunize,
immunize!
• Supportive care only with parent
education
Cytomegalovirus (CMV)
• Most common congenital viral infection
• ~40,000 infants per year in the U.S.
• Mild, self limiting illness
• Transmission can occur with primary infection
or reactivation of virus
• 40% risk of transmission in primary infxn
• Studies suggest increased risk of
transmission later in pregnancy
• However, more severe sequalae associated with
earlier acquisition
Clinical Manifestations
• 90% are asymptomatic at birth!
• Up to 15% develop symptoms later,
notably sensorineural hearing loss
• Symptomatic infection
• SGA, HSM, petechiae, jaundice,
chorioretinitis, periventricular calcifications,
neurological deficits
• >80% develop long term complications
• Hearing loss, vision impairment, developmental
delay
Ventriculomegaly and
calcifications of
congenital CMV
Diagnosis
• Maternal IgG shows only past infection
• Infection common – this is useless
• Viral isolation from urine or saliva in 1st
3weeks of life
• Afterwards may represent post-natal infection
• Viral load and DNA copies can be assessed
by PCR
• Less useful for diagnosis, but helps in following
viral activity in patient
• Serologies not helpful given high antibody in
population
Treatment
• Ganciclovir x6wks in symptomatic infants
• Studies show improvement or no progression of
hearing loss at 6mos
• No other outcomes evaluated (development, etc.)
• Neutropenia often leads to cessation of therapy
• Treatment currently not recommended in
asymptomatic infants due to side effects
• Area of active research to include use of
valgancyclovir, treating asx patients, etc.
Herpes Simplex (HSV)
• HSV1 or HSV2
• Primarily transmitted through infected
maternal genital tract
• Rationale for C-section delivery prior to
membrane rupture
• Primary infection with greater
transmission risk than reactivation
Clinical Manifestations
• Most are asymptomatic at birth
• 3 patterns of ~ equal frequency with
symptoms between birth and 4wks:
• Skin, eyes, mouth (SEM)
• CNS disease
• Disseminated disease (present earliest)
• Initial manifestations very nonspecific with
skin lesions NOT necessarily present
Presentations of congenital HSV
Diagnosis
• Culture of maternal lesions if present at
delivery
• Cultures in infant:
• Skin lesions, oro/nasopharynx, eyes, urine, blood,
rectum/stool, CSF
• CSF PCR
• Serologies again not helpful given high
prevalence of HSV antibodies in population
Treatment
• High dose acyclovir 60mg/kg/day
divided q8hrs
• X21days for disseminated, CNS disease
• X14days for SEM
• Ocular involvement requires topical
therapy as well
34061_TORCH_maranich.ppt
Which TORCH Infection Presents
With…
• Snuffles?
• syphilis
• Chorioretinitis, hydrocephalus, and
intracranial calcifications?
• toxo
• Blueberry muffin lesions?
• rubella
• Periventricular calcifications?
• CMV
• No symptoms?
• All of them
Which TORCH Infections Can
Absolutely Be Prevented?
• Rubella
• Syphilis
When Are TORCH Titers Helpful
in Diagnosing Congenital
Infection?
• NEVER!
Questions?

More Related Content

PPT
Torch infections
PPTX
TORCH Infections.pptx
PPT
-Torch-Infection-Easier model for starters.ppt
PPT
Infections in pregnancy 1 3 15
PDF
Common TORCH Infection that affect pediatrics
PPT
Etiology and lab diagnosis of Congenital Infections.ppt
PPTX
PPTX
Perinatal infections (2)
Torch infections
TORCH Infections.pptx
-Torch-Infection-Easier model for starters.ppt
Infections in pregnancy 1 3 15
Common TORCH Infection that affect pediatrics
Etiology and lab diagnosis of Congenital Infections.ppt
Perinatal infections (2)

Similar to 34061_TORCH_maranich.ppt (20)

PPTX
PPT
Transplacental Cytomegalo virus infections.ppt
PPTX
Congenital infections zac
PPTX
Torch infection in pregnancy
PPTX
INTRAUTERINE INFECTIONS (TORCH INFECTIONS)
PPTX
perinatal infection.pptx
PPTX
neonatal infectious diseases categories.pptx
PPTX
Fbgd6hkDe42Xjgl5990.pptx
PPTX
Congenital infection
PPTX
TORCH INFECTIONS IN PREGNANCY.pptx
PPTX
Infections in pregnancy, foetus and neonates
PPTX
neonatal infection(7392992y282939y5.pptx
PPTX
Perinatal infections- Diagnosis & Management - Dr Padmesh - Neonatology
PPTX
416575945-Torch-Infection.pptx. easy model
PPT
Diagnosis And Therapy Of Perinatal Infection
PDF
perinatal infections diagnosis treatment .pdf
PPT
Torch Infection
PDF
TORCH (TORCH).pdf
PPT
Torch infections
PDF
presentation2-150208112421-conversion-gate02.pdf
Transplacental Cytomegalo virus infections.ppt
Congenital infections zac
Torch infection in pregnancy
INTRAUTERINE INFECTIONS (TORCH INFECTIONS)
perinatal infection.pptx
neonatal infectious diseases categories.pptx
Fbgd6hkDe42Xjgl5990.pptx
Congenital infection
TORCH INFECTIONS IN PREGNANCY.pptx
Infections in pregnancy, foetus and neonates
neonatal infection(7392992y282939y5.pptx
Perinatal infections- Diagnosis & Management - Dr Padmesh - Neonatology
416575945-Torch-Infection.pptx. easy model
Diagnosis And Therapy Of Perinatal Infection
perinatal infections diagnosis treatment .pdf
Torch Infection
TORCH (TORCH).pdf
Torch infections
presentation2-150208112421-conversion-gate02.pdf

Recently uploaded (20)

PDF
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
PDF
TR - Agricultural Crops Production NC III.pdf
PDF
Complications of Minimal Access Surgery at WLH
PPTX
master seminar digital applications in india
PDF
Basic Mud Logging Guide for educational purpose
PPTX
Lesson notes of climatology university.
PDF
Insiders guide to clinical Medicine.pdf
PDF
Module 4: Burden of Disease Tutorial Slides S2 2025
PPTX
Cell Structure & Organelles in detailed.
PDF
Computing-Curriculum for Schools in Ghana
PDF
Physiotherapy_for_Respiratory_and_Cardiac_Problems WEBBER.pdf
PPTX
Institutional Correction lecture only . . .
PDF
102 student loan defaulters named and shamed – Is someone you know on the list?
PDF
STATICS OF THE RIGID BODIES Hibbelers.pdf
PPTX
human mycosis Human fungal infections are called human mycosis..pptx
PPTX
Microbial diseases, their pathogenesis and prophylaxis
PDF
ANTIBIOTICS.pptx.pdf………………… xxxxxxxxxxxxx
PDF
Supply Chain Operations Speaking Notes -ICLT Program
PPTX
Introduction_to_Human_Anatomy_and_Physiology_for_B.Pharm.pptx
PDF
Saundersa Comprehensive Review for the NCLEX-RN Examination.pdf
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
TR - Agricultural Crops Production NC III.pdf
Complications of Minimal Access Surgery at WLH
master seminar digital applications in india
Basic Mud Logging Guide for educational purpose
Lesson notes of climatology university.
Insiders guide to clinical Medicine.pdf
Module 4: Burden of Disease Tutorial Slides S2 2025
Cell Structure & Organelles in detailed.
Computing-Curriculum for Schools in Ghana
Physiotherapy_for_Respiratory_and_Cardiac_Problems WEBBER.pdf
Institutional Correction lecture only . . .
102 student loan defaulters named and shamed – Is someone you know on the list?
STATICS OF THE RIGID BODIES Hibbelers.pdf
human mycosis Human fungal infections are called human mycosis..pptx
Microbial diseases, their pathogenesis and prophylaxis
ANTIBIOTICS.pptx.pdf………………… xxxxxxxxxxxxx
Supply Chain Operations Speaking Notes -ICLT Program
Introduction_to_Human_Anatomy_and_Physiology_for_B.Pharm.pptx
Saundersa Comprehensive Review for the NCLEX-RN Examination.pdf

34061_TORCH_maranich.ppt

  • 2. TORCH Infections • T=toxoplasmosis • O=other (syphilis) • R=rubella • C=cytomegalovirus (CMV) • H=herpes simplex (HSV)
  • 3. • You are taking care of a term newborn male with birth weight/length <10th %ile. Physical exam is normal except for a slightly enlarged liver span. A CBC is significant for low platelets. • What, if anything, do you worry about? • How do you proceed with a work-up?
  • 4. Index of Suspicion • When do you think of TORCH infections? • IUGR infants • HSM • Thrombocytopenia • Unusual rash • Concerning maternal history • “Classic” findings of any specific infection
  • 5. Diagnosing TORCH Infection !!!!!!DO NOT USE TORCH TITERS!!!!!!
  • 6. Diagnosing TORCH Infection • Good maternal/prenatal history • Remember most infections of concern are mild illnesses often unrecognized • Thorough exam of infant • Directed labs/studies based on most likely diagnosis… • Again, DO NOT USE TORCH TITERS!
  • 7. Screening TORCH Infections • Retrospective study of 75/182 infants with IUGR who were screened for TORCH infections • 1/75 with clinical findings, 11/75 with abnl lab findings • All patients screened: • TORCH titers, urine CMV culture, head US • Only 3 diagnosed with infection • NONE by TORCH titer!! • Overall cost of all tests = $51,715 • “Shotgun” screening approach NOT cost effective nor particularly useful • Diagnostic work-up should be logical and directed by history/exam findings Khan, NA, Kazzi, SN. Yield and costs of screening growth-retarded infants for torch
  • 8. Toxoplasmosis • Caused by protozoan – Toxoplasma gondii • Domestic cat is the definitive host with infections via: • Ingestion of cysts (meats, garden products) • Contact with oocysts in feces • Much higher prevalence of infection in European countries (ie France, Greece) • Acute infection usually asymptomatic • 1/3 risk of fetal infection with primary maternal infection in pregnancy • Infection rate higher with infxn in 3rd trimester • Fetal death higher with infxn in 1st trimester
  • 9. Clinical Manifestations • Most (70-90%) are asymptomatic at birth • Classic triad of symptoms: • Chorioretinitis • Hydrocephalus • Intracranial calcifications • Other symptoms include fever, rash, HSM, microcephaly, seizures, jaundice, thrombocytopenia, lymphadenopathy • Initially asymptomatic infants are still at high risk of developing abnormalities, especially chorioretinitis
  • 11. Diagnosis • Maternal IgG testing indicates past infection (but when…?) • Can be isolated in culture from placenta, umbilical cord, infant serum • PCR testing on WBC, CSF, placenta • Not standardized • Newborn serologies with IgM/IgA
  • 12. Toxo Screening • Prenatal testing with varied sensitivity not useful for screening • Neonatal screening with IgM testing implemented in some areas • Identifies infected asymptomatic infants who may benefit from therapy
  • 13. Prevention and Treatment • Treatment for pregnant mothers diagnosed with acute toxo • Spiramycin daily • Macrolide antibiotic • Small studies have shown this reduces likelihood of congenital transmission (up to 50%) • If infant diagnosed prenatally, treat mom • Spiramycin, pyrimethamine (anti-malarial, dihydrofolate reductase inhib), and sulfadiazine (sulfa antibiotic) • Leucovorin rescue with pyrimethamine • Symptomatic infants • Pyrimethamine (with leucovorin rescue) and sulfadiazine • Treatment for 12 months total • Asymptomatic infants • Course of same medications • Improved neurologic and developmental outcomes demonstrated (compared to untreated pts or those treated for only one month)
  • 14. Syphilis • Treponema pallidum (spirochete) • Transmitted via sexual contact • Placental transmission as early as 6wks gestation • Typically occurs during second half • Mom with primary or secondary syphilis more likely to transmit than latent disease • Large decrease in congenital syphilis since late 1990s • In 2002, only 11.2 cases/100,000 live births reported
  • 17. Congenital Syphilis • 2/3 of affected live-born infants are asymptomatic at birth • Clinical symptoms split into early or late (2 years is cutoff) • 3 major classifications: • Fetal effects • Early effects • Late effects
  • 18. Clinical Manifestations • Fetal: • Stillbirth • Neonatal death • Hydrops fetalis • Intrauterine death in 25% • Perinatal mortality in 25-30% if untreated
  • 19. Clinical Manifestations • Early congenital (typically 1st 5 weeks): • Cutaneous lesions (palms/soles) • HSM • Jaundice • Anemia • Snuffles • Periostitis and metaphysial dystrophy • Funisitis (umbilical cord vasculitis)
  • 20. Periostitis of long bones seen in neonatal syphilis
  • 21. Clinical Manifestations • Late congenital: • Frontal bossing • Short maxilla • High palatal arch • Hutchinson teeth • 8th nerve deafness • Saddle nose • Perioral fissures • Can be prevented with appropriate treatment
  • 22. Hutchinson teeth – late result of congenital syphilis
  • 23. Diagnosing Syphilis (Not in Newborns) • Available serologic testing • RPR/VDRL: nontreponemal test • Sensitive but NOT specific • Quantitative, so can follow to determine disease activity and treatment response • MHA-TP/FTA-ABS: specific treponemal test • Used for confirmatory testing • Qualitative, once positive always positive • RPR/VDRL screen in ALL pregnant women early in pregnancy and at time of birth • This is easily treated!!
  • 24. CDC Definition of Congenital Syphilis • Confirmed if T. pallidum identified in skin lesions, placenta, umbilical cord, or at autopsy • Presumptive diagnosis if any of: • Physical exam findings • CSF findings (positive VDRL) • Osteitis on long bone x-rays • Funisitis (“barber shop pole” umbilical cord) • RPR/VDRL >4 times maternal test • Positive IgM antibody
  • 25. Diagnosing Congenital Syphilis • IgG can represent maternal antibody, not infant infection • This is VERY intricate and often confusing • Consult your RedBook (or peds ID folks) when faced with this situation
  • 26. Treatment • Penicillin G is THE drug of choice for ALL syphilis infections • Maternal treatment during pregnancy very effective (overall 98% success) • Treat newborn if: • They meet CDC diagnostic criteria • Mom was treated <4wks before delivery • Mom treated with non-PCN med • Maternal titers do not show adequate response (less than 4-fold decline)
  • 27. Rubella • Single-stranded RNA virus • Vaccine-preventable disease • No longer considered endemic in the U.S. • Mild, self-limiting illness • Infection earlier in pregnancy has a higher probability of affected infant
  • 28. Copyright ©2006 American Academy of Pediatrics Meissner, H. C. et al. Pediatrics 2006;117:933-935 Reported rubella and CRS: United States, 1966-2004
  • 29. Clinical Manifestations • Sensorineural hearing loss (50-75%) • Cataracts and glaucoma (20-50%) • Cardiac malformations (20-50%) • Neurologic (10-20%) • Others to include growth retardation, bone disease, HSM, thrombocytopenia, “blueberry muffin” lesions
  • 30. “Blueberry muffin” spots representing extramedullary hematopoesis
  • 31. Diagnosis • Maternal IgG may represent immunization or past infection - Useless! • Can isolate virus from nasal secretions • Less frequently from throat, blood, urine, CSF • Serologic testing • IgM = recent postnatal or congenital infection • Rising monthly IgG titers suggest congenital infection • Diagnosis after 1 year of age difficult to establish
  • 32. Treatment • Prevention…immunize, immunize, immunize! • Supportive care only with parent education
  • 33. Cytomegalovirus (CMV) • Most common congenital viral infection • ~40,000 infants per year in the U.S. • Mild, self limiting illness • Transmission can occur with primary infection or reactivation of virus • 40% risk of transmission in primary infxn • Studies suggest increased risk of transmission later in pregnancy • However, more severe sequalae associated with earlier acquisition
  • 34. Clinical Manifestations • 90% are asymptomatic at birth! • Up to 15% develop symptoms later, notably sensorineural hearing loss • Symptomatic infection • SGA, HSM, petechiae, jaundice, chorioretinitis, periventricular calcifications, neurological deficits • >80% develop long term complications • Hearing loss, vision impairment, developmental delay
  • 36. Diagnosis • Maternal IgG shows only past infection • Infection common – this is useless • Viral isolation from urine or saliva in 1st 3weeks of life • Afterwards may represent post-natal infection • Viral load and DNA copies can be assessed by PCR • Less useful for diagnosis, but helps in following viral activity in patient • Serologies not helpful given high antibody in population
  • 37. Treatment • Ganciclovir x6wks in symptomatic infants • Studies show improvement or no progression of hearing loss at 6mos • No other outcomes evaluated (development, etc.) • Neutropenia often leads to cessation of therapy • Treatment currently not recommended in asymptomatic infants due to side effects • Area of active research to include use of valgancyclovir, treating asx patients, etc.
  • 38. Herpes Simplex (HSV) • HSV1 or HSV2 • Primarily transmitted through infected maternal genital tract • Rationale for C-section delivery prior to membrane rupture • Primary infection with greater transmission risk than reactivation
  • 39. Clinical Manifestations • Most are asymptomatic at birth • 3 patterns of ~ equal frequency with symptoms between birth and 4wks: • Skin, eyes, mouth (SEM) • CNS disease • Disseminated disease (present earliest) • Initial manifestations very nonspecific with skin lesions NOT necessarily present
  • 41. Diagnosis • Culture of maternal lesions if present at delivery • Cultures in infant: • Skin lesions, oro/nasopharynx, eyes, urine, blood, rectum/stool, CSF • CSF PCR • Serologies again not helpful given high prevalence of HSV antibodies in population
  • 42. Treatment • High dose acyclovir 60mg/kg/day divided q8hrs • X21days for disseminated, CNS disease • X14days for SEM • Ocular involvement requires topical therapy as well
  • 44. Which TORCH Infection Presents With… • Snuffles? • syphilis • Chorioretinitis, hydrocephalus, and intracranial calcifications? • toxo • Blueberry muffin lesions? • rubella • Periventricular calcifications? • CMV • No symptoms? • All of them
  • 45. Which TORCH Infections Can Absolutely Be Prevented? • Rubella • Syphilis
  • 46. When Are TORCH Titers Helpful in Diagnosing Congenital Infection? • NEVER!